Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alosetron effect on mucosal blood flow in d-IBS and healthy females
NCT00370032Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Alosetron in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by GSK. Started Dec 2006; status: completed.
02
Drugs
Alosetron
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT00370032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370032.